Indivior Pharmaceuticals, Inc. Common Stock (INDV) is a publicly traded Healthcare sector company. As of October 15, 2026, INDV trades at $33.62 with a market cap of $4.03B and a P/E ratio of 12.57. INDV moved -1.58% today. Year to date, INDV is -5.91%; over the trailing twelve months it is +33.47%. Its 52-week range spans $7.62 to $42.81. Analyst consensus is strong buy with an average price target of $45.50. Rallies surfaces INDV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks INDV insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $33.62 |
| Market Cap | $4.03B |
| P/E Ratio | 12.57 |
| EPS | $2.88 |
| Dividend Yield | 8.13% |
| 52-Week High | $42.81 |
| 52-Week Low | $7.62 |
| Volume | 712.74K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.33B |
| Net Income | $355.00M |
| Gross Margin | 81.98% |
3 analysts cover INDV: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $45.50.